Online citations, reference lists, and bibliographies.
← Back to Search

Formulation And Evaluation Of Nano Based Drug Delivery System For The Buccal Delivery Of Acyclovir.

Bandar E Aldhubiab, Anroop B Nair, R. Kumria, M. Attimarad, S. Harsha
Published 2015 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Oral bioavailability of acyclovir is limited, primarily because of low permeability across the gastrointestinal membrane. The purpose of this study is the prospective evaluation of buccal films impregnated with acyclovir loaded nanospheres as a drug delivery system to improve systemic bioavailability. Acyclovir polymeric nanospheres were prepared by double emulsion solvent evaporation technique. Nanospheres were embedded into buccoadhesive films (A1-A4) comprising of different concentrations of polymers (Eudragit RL 100, HPMC K15 and carbopol 974P). Films were characterized for physico-mechanical properties, mucoadhesive strength, hydration, drug release and ex vivo permeation. In vivo studies were carried out on rabbits to assess the pharmacokinetic profile of buccal film (A3) as compared to oral therapy. The prepared films demonstrated excellent physical properties, adequate hydration and buccoadhesive strength. In vitro drug release data inferred that the drug release was dependent on the composition of film. Ex vivo permeation studies indicated greater flux in film A3. In vivo studies revealed a significant enhancement in absorption of acyclovir (P<0.0001) with Cmax (~3 folds) and AUC0-α (~8 folds, P<0.0001) when compared to oral dosing. Moreover, the extended Tmax value (6h) signifies the potential of the prepared film to prolong acyclovir delivery. Given the promising results, the study concludes that the developed buccal film (A3) impregnated with acyclovir loaded nanospheres could be a promising approach for effective delivery of acyclovir.
This paper references
10.3109/03639045.2014.884125
Loratidine buccal films for allergic rhinitis: development and evaluation
R. Kumria (2014)
10.2165/00003088-198308030-00001
Clinical Pharmacokinetics of Acyclovir
O. Laskin (1983)
10.1016/j.jconrel.2009.06.014
Oral strip technology: overview and future potential.
R. Dixit (2009)
10.3109/10717544.2014.920058
Buccal films of prednisolone with enhanced bioavailability
R. Kumria (2016)
10.3109/10717544.2014.948644
Development and evaluation of buccal films impregnated with selegiline-loaded nanospheres
Bandar E Aldhubiab (2016)
10.1016/j.pcl.2012.12.005
Neonatal herpes simplex virus infections.
S. Pinninti (2013)
10.1016/S0928-0987(02)00047-7
Synthesis of analogs of L-valacyclovir and determination of their substrate activity for the oligopeptide transporter in Caco-2 cells.
G. Friedrichsen (2002)
10.1097/OLQ.0b013e318286bb53
Sexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2008
C. Satterwhite (2013)
10.1155/2012/385697
Herpes Simplex Virus Infection in Pregnancy
G. Straface (2012)
10.3109/03639045.2012.738682
Design and development of multiple emulsion for enhancement of oral bioavailability of acyclovir
Sumita Paul (2013)
10.1016/J.ADDR.2005.07.003
The use of mucoadhesive polymers in buccal drug delivery.
Nazila Salamat-Miller (2005)
10.1056/NEJMra0807633
Maternal and neonatal herpes simplex virus infections.
L. Corey (2009)
10.3109/10717544.2013.853213
Enhanced oral bioavailability of acyclovir by inclusion complex using hydroxypropyl-β-cyclodextrin
Anroop B Nair (2014)
10.1586/14787210.2014.880337
Acyclovir Lauriad®: a muco-adhesive buccal tablet for the treatment of recurrent herpes labialis
C. Downing (2014)
10.1002/jps.21392
Biowaiver monographs for immediate release solid oral dosage forms: aciclovir.
J. Arnal (2008)
10.1016/j.oooo.2014.08.015
Local delivery of imiquimod in hamsters using mucoadhesive films and their residence time in human patients.
Sandeep Ramineni (2014)
10.1007/978-1-4613-1715-9_6
Treatment of herpes simplex labialis.
S. Spruance (1990)
Epidemiology of genital herpes simplex virus infection in developed countries.
Jean-Elie Malkin (2004)
10.1016/S0142-9612(00)00134-4
Enhancing effect of chitosan on peptide drug delivery across buccal mucosa.
S. Şenel (2000)
10.1016/j.colsurfb.2014.05.025
Films loaded with insulin-coated nanoparticles (ICNP) as potential platforms for peptide buccal delivery.
Javier O Morales (2014)
10.1517/17425240802450340
Acyclovir delivery systems
R. Cortesi (2008)
10.1016/j.ijpharm.2012.02.035
Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules.
Concetta Giovino (2012)
10.1111/jphp.12046
Protein‐coated nanoparticles embedded in films as delivery platforms
Javier O Morales (2013)
10.1016/J.JCONREL.2006.04.012
Buccal bioadhesive drug delivery--a promising option for orally less efficient drugs.
Y. Sudhakar (2006)
10.1002/JPS.20765
Biowaiver monographs for immediate release solid oral dosage forms: isoniazid.
C. Becker (2007)
10.3109/10717544.2013.779331
Formulation and evaluation of mucoadhesive buccal films impregnated with carvedilol nanosuspension: a potential approach for delivery of drugs having high first-pass metabolism
P. Rana (2013)
10.7555/JBR.27.20120136
A clinical perspective on mucoadhesive buccal drug delivery systems
R. Gilhotra (2014)
10.1016/j.jconrel.2012.11.019
In vitro techniques to evaluate buccal films.
Anroop B Nair (2013)
10.4172/JBB.1000073
Comparative Pharmacokinetics, Safety and Tolerability Evaluation of Acyclovir IR 800 Mg Tablet in Healthy Indian Adult Volunteers Under Fasting and Non-fasting Conditions
P. Susantakumar (2011)
10.1016/j.jsps.2011.04.001
Nanoparticles: Emerging carriers for drug delivery.
S. R. Mudshinge (2011)
10.3109/10717544.2014.896958
Design, development and characterization of buccal bioadhesive films of Doxepin for treatment of odontalgia
H. Castán (2015)
10.1177/106002809402800407
Acute Renal Failure and Neurotoxicity following Oral Acyclovir
G. Johnson (1994)
10.1016/j.ejps.2012.11.002
Nano and microparticulate chitosan-based systems for antiviral topical delivery.
L. Calderón (2013)
10.1016/J.JCONREL.2007.03.012
Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody.
P. Kocbek (2007)
10.1016/0002-9343(82)90115-2
Topical 5 percent acyclovir in polyethylene glycol for herpes simplex labialis. Antiviral effect without clinical benefit.
S. Spruance (1982)
10.2174/156720109788680895
Transdermal delivery of atenolol: effect of prodrugs and iontophoresis.
Anroop B Nair (2009)
10.3851/IMP2970
Quantification of uptake and clearance of acyclovir in skin layers.
Anroop B Nair (2016)
10.1053/J.SPID.2004.09.006
Neonatal herpes: what have we learned.
D. Kimberlin (2005)
10.1080/10837450701563277
In Vitro Controlled Release of Alfuzosin Hydrochloride Using HPMC-Based Matrix Tablets and Its Comparison with Marketed Product
Anroop B Nair (2007)
10.1016/J.JCONREL.2007.09.013
Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
R. C. Mundargi (2008)



This paper is referenced by
10.1590/1807-3107BOR-2016.vol30.0126
In vitro and in vivo evaluation of nano-based films for buccal delivery of zolpidem.
Bandar E Aldhubiab (2016)
10.3390/ma12244239
HPMC- and PLGA-Based Nanoparticles for the Mucoadhesive Delivery of Sitagliptin: Optimization and In Vivo Evaluation in Rats
Anroop B Nair (2019)
Development and in vitro assessment of Norfloxacin nanoparticles
Bandar E Aldhubiab (2018)
10.3390/pharmaceutics11050230
Nanoemulsion Based Vehicle for Effective Ocular Delivery of Moxifloxacin Using Experimental Design and Pharmacokinetic Study in Rabbits
Jigar Shah (2019)
10.2217/nnm-2018-0089
Polyethylene glycol-coated zinc oxide nanoparticle: an efficient nanoweapon to fight against herpes simplex virus type 1.
A. Tavakoli (2018)
10.1016/j.ijbiomac.2018.01.215
Determination of diffusion coefficient for released nanoparticles from developed gelatin/chitosan bilayered buccal films.
Zahra Mahdizadeh Barzoki (2018)
10.1177/2049936117713593
The role of nanotechnology in the treatment of viral infections
Lavanya Singh (2017)
10.1016/j.ajps.2019.05.001
Enhancement in antinociceptive and anti-inflammatory effects of tramadol by transdermal proniosome gel
Jigar N Shah (2020)
10.1016/b978-0-08-102828-5.00009-7
Polymer-based nanoparticles for biomedical applications
B. Shkodra-Pula (2020)
10.1016/j.nantod.2020.101031
Nanotechnology for virus treatment
J. Zhou (2021)
10.1002/ddr.21452
Cyclodextrin complexes: Perspective from drug delivery and formulation
Shery Jacob (2018)
10.1080/21691401.2018.1463230
Non-invasive systemic drug delivery through mucosal routes
Amit Goyal (2018)
10.31925/FARMACIA.2019.2.12
DEVELOPMENT AND EVALUATION OF NEBIVOLOL HYDROCHLORIDE NANOCRYSTALS IMPREGNATED BUCCAL FILM
Bandar E Aldhubiab (2019)
10.3390/nano11010137
Inorganic and Polymeric Nanoparticles for Human Viral and Bacterial Infections Prevention and Treatment
J. J. Aguilera-Correa (2021)
10.5505/TJPS.2016.05706
Mucoadhesive buccal films embedded with antiviral drug loaded nanospheres
Bandar E Aldhubiab (2016)
10.2147/IJN.S256925
Enhancement of Simvastatin ex vivo Permeation from Mucoadhesive Buccal Films Loaded with Dual Drug Release Carriers
T. Ahmed (2020)
10.1016/j.carbpol.2018.04.032
Incorporation of beads into oral films for buccal and oral delivery of bioactive molecules.
P. Castro (2018)
10.5530/JYP.2017.9.19
Mucoadhesive Film Embedded with Acyclovir Loaded Biopolymeric Nanoparticles: In vitro Studies
Anroop B Nair (2017)
10.1016/j.ijpharm.2018.05.051
Combination of PLGA nanoparticles with mucoadhesive guar‐gum films for buccal delivery of antihypertensive peptide
P. Castro (2018)
10.1016/j.ejps.2018.05.009
Dissolving polymeric microneedle arrays for enhanced site‐specific acyclovir delivery
Boonnada Pamornpathomkul (2018)
10.1016/j.jpba.2017.06.072
An overview of in vitro dissolution/release methods for novel mucosal drug delivery systems
M. Jug (2018)
10.1016/J.JDDST.2018.08.014
Development and evaluation of palonosetron loaded mucoadhesive buccal films
Anroop B Nair (2018)
10.2174/0929867325666180309105519
Acyclovir in the Treatment of Herpes Viruses - a Review.
Katarzyna Klysik (2018)
10.5209/RCCV.55359
Uso de nanopartículas en las formulaciones de Aciclovir.
A. S. Belloso (2017)
10.1016/j.jconrel.2020.01.006
Novel and revisited approaches in nanoparticle systems for buccal drug delivery.
A. S. Macedo (2020)
10.1016/j.ijpharm.2019.118697
Recent developments of nanoparticle-delivered dosage forms for buccal delivery.
P. Tran (2019)
10.3389/fphar.2019.01057
Pharmacokinetic Aspects of Nanoparticle-in-Matrix Drug Delivery Systems for Oral/Buccal Delivery
Renata de Carvalho Feitosa (2019)
10.1080/08982104.2016.1224897
Preparation and evaluation of niosome gel containing acyclovir for enhanced dermal deposition
Shery Jacob (2017)
10.1007/s12247-018-9312-6
Formulation and Evaluation of Chitosan-Based Buccal Bioadhesive Films of Zolmitriptan
R. Kumria (2018)
10.1016/j.ejps.2018.05.016
Acyclovir lipid nanocapsules gel for oromucosal delivery: A preclinical evidence of efficacy in the chicken pouch membrane model
Darine Abozaid (2018)
10.1016/J.REACTFUNCTPOLYM.2016.01.011
Mucoadhesion: A promising approach in drug delivery system
Shakir Mansuri (2016)
10.1016/j.jpba.2017.06.071
Current antiviral drugs and their analysis in biological materials—Part I: Antivirals against respiratory and herpes viruses
L. Nováková (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar